ANADA 200-591, Approved by FDA
INFORMING COW-CALF, STOCKER AND FEEDYARD PRODUCERS
WHAT’S INSIDE THE VITALITY OF RURAL AMERICA OCTOBER | NOVEMBER 2023
For intramuscular and subcutaneous use in beef and non-lactating dairy cattle only. BRIEF SUMMARY (For full Prescribing Information, see package insert.) INDICATIONS: Norfenicol is indicated for treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, and for the treatment of foot rot . Also, it is indicated for control of respiratory disease in cattle at high risk of developing BRD associated with M.haemolytica, P. multocida, and H. somni. CONTRAINDICATIONS: Do not use in animals that have shown hypersensitivity to florfenicol. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. Can be irritating to skin and eyes. Avoid direct contact with skin, eyes, and clothing. In case of accidental eye exposure, flush with water for 15 minutes. In case of accidental skin exposure, wash with soap and water. Remove contaminated clothing. Consult physician if irritation persists. Accidental injection of this product may cause local irritation. Consult physician immediately. The risk information provided here is not comprehensive. To learn more, talk about Norfenicol with your veterinarian. For customer service, adverse effects reporting, or to obtain a copy of the MSDS or FDA-approved package insert, call 1-866-591-5777. PRECAUTIONS: Not for use in animals intended for breeding. Effects on bovine reproductive performance, pregnancy, and lactation have not been determined. Intramuscular injection may result in local tissue reaction which persists beyond 28 days. This may result in trim loss at slaughter. Tissue reaction at injection sites other than the neck is likely to be more severe. RESIDUE WARNINGS: Animals intended for human consumption must not be slaughtered within 28 days of the last intramuscular treatment. Animals intended for human consumption must not be slaughtered within 33 days of subcutaneous treatment. Not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows as such use may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established ADVERSE REACTIONS: Inappetence, decreased water consumption, or diarrhea may occur transiently. Manufactured by: Norbrook Laboratories Limited, Newry, BT35 6PU, Co. Down, Northern Ireland. The Norbrook logos and Norfenicol ® are registered trademarks of Norbrook Laboratories Limited. in pre-ruminating calves. Do not use in calves to be processed for veal.
COVER STORIES
22 Prime Points 25 All In 26 Rumblings From the Great White North 27 Beyond the Ranch Gate 28 Whitt & Wisdom CALF VOICES
14 UNL BARTA BROTHERS RANCH OPEN HOUSE 16 CBB CHAIR JIMMY TAYLOR 6 U.S. BEEF PRODUCTION FROM A U.K. PERSPECTIVE PART 1 8 WILL CATTLE PRICES SURGE EVEN HIGHER IN 2024?
SPECIAL FEATURES 10 Nebraskans Well Represented in Hall of Fame 18 Spicer Gripp Memorial Roping Boosts West Texas A&M Agriculture 15 Zoetis Introduces Valcor Endectocide 20 2023 IFCA Finals
IN EVERY ISSUE
5 Gypsy Wagon 31 Chuteside Manner 34 Hot Off the Grill 35 Where’s the Really Exceptional Beef? 36 On the Human Side 37 CALF's Featured Lady 37 Gatherings 38 Events Calendar 38 Flatland Philosopher 38 Index of Advertisers
On The Cover: Looking out over the rural landscape of America, rodeos and county fairs and ranchers like Jimmy Taylor and the Barta Brothers remind us of the resiliency of our roots.
3
Made with FlippingBook interactive PDF creator